A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

Brief description of study

The main goal of this study is to determine if limited surgery or high dose precision radiation is better in patients who are at an elevated risk for surgical complications with early stage lung cancer.

Clinical Study Identifier: s16-02247

ClinicalTrials.gov Identifier: NCT02468024

Principal Investigator: Benjamin Cooper.

Other Investigators: Salman Rafi Punekar, Kamini Barat, Harvey I Pass, Peter B. Schiff, Sally Lau.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies